Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Ongoing Initiated Oct 31, 2025 (11 months ago)

Cook-Walte (Mepivacaine Hydrochloride)

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Defective container: cracked/broken cartridges

Cause type: Packaging defect

Failed child-resistant closures, leaks, cracked containers, or a defective delivery device. Packaging failures risk accidental exposure (especially to children) or product contamination. All packaging defect recalls.

What was recalled

Cook-Walte, Carbocaine 3% (30 mg/mL), (mepivacaine hydrochloride Injection, USP), packaged in a carton containing 50 Single-Dose Cartridges, 1.7 mL, Rx only, Manufactured by Novocol Pharmaceutical of Canada, Inc., NDC 0362-0753-05.

Affected NDC 0362-0753-05

Compare with the code on your package — it is the most precise check available.

Drug: Mepivacaine

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Carbocaine
Mepivacaine Hydrochloride
NDC 00362-0753
30 mg/mL Injection, Solution
Submucosal
Septodont, Inc. Rx
Recalling firm
Novocol Pharmaceutical of Canada, Inc.
NDC code
0362-0753-05
Origin
Canada
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0233-2026 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall.

Other Mepivacaine recalls

See all
Class II · Moderate risk

darby dental supply

Defective container: cracked/broken cartridges

Ongoing Packaging defect Novocol Pharmaceutical of Canada, Inc. NDC 66467-9760-5 D-0231-2026
Class II · Moderate risk

3% Polocaine DENTAL

Defective container: cracked/broken cartridges

Ongoing Packaging defect Novocol Pharmaceutical of Canada, Inc. NDC 66312-441-16 D-0230-2026
Class II · Moderate risk

Mepivacaine HCl active pharmaceutical ingredient packaged in…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-779-2015

Other recalls by Novocol Pharmaceutical of Canada, Inc.

All 2025 recalls
Class II · Moderate risk

OraVerse

Defective container: cracked/broken cartridges

Ongoing Packaging defect Novocol Pharmaceutical of Canada, Inc. NDC 0362-0101-10 D-0234-2026
Class II · Moderate risk

darby dental supply

Defective container: cracked/broken cartridges

Ongoing Packaging defect Novocol Pharmaceutical of Canada, Inc. NDC 66467-9760-5 D-0231-2026
Class II · Moderate risk

3% Polocaine DENTAL

Defective container: cracked/broken cartridges

Ongoing Packaging defect Novocol Pharmaceutical of Canada, Inc. NDC 66312-441-16 D-0230-2026